Báo cáo y học: "Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. | Available online http content 8 3 R83 Open Access Research article Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy a pilot study Mónica Vigna-Perez1 Berenice Hernandez-Castro1 Octavio Paredes-Saharopulos1 Diana Portales-Perez2 Lourdes Baranda1 3 Carlos Abud-Mendoza3 and Roberto Gonzalez-Amaro1 1Departamento de Inmunología Facultad de Medicina UASLP San Luis Potosí SLP Mexico 2Laboratorio de Inmunología Celular y Molecular Facultad de Ciencias Químicas UASLP San Luis Potosí SLP Mexico 3Unidad Regional de Reumatología y Osteoporosis Hospital Central Dr Ignacio Morones Prieto San Luis Potosí SLP Mexico Corresponding author Roberto Gonzalez-Amaro rgonzale@ Received 11 Dec 2005 Revisions requested 16 Jan 2006 Revisions received 9 Feb 2006 Accepted 10 Apr 2006 Published 5 May 2006 Arthritis Research Therapy 2006 8 R83 doi ar1 954 This article is online at http content 8 3 R83 2006 Vigna-Perez et al. licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract We studied the clinical and immunological effects of Rituximab anti-CD20 therapy in patients with lupus nephritis. In an open clinical trial 22 patients with active systemic lupus erythematosis and renal involvement mainly class III and IV according to the WHO classification that was refractory to conventional therapy were studied. In all these patients Rituximab to g at days 1 and 15 was added to the immunosuppressive therapy and its therapeutic effect was evaluated. In addition the levels and function of regulatory T lymphocytes and the apoptosis of immune cells were assessed. We found a significant reduction in disease activity p .

Không thể tạo bản xem trước, hãy bấm tải xuống
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
113    88    6    12-05-2024
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.